Organigram (OGI) Holdings announced its official rebrand to Organigram Global. Having achieved the number one position in market share in Canada, Organigram Global is now focused on accelerating its global expansion and strengthening its presence in key international markets. The evolution to Organigram Global includes a bold new logo, a refreshed visual identity, and a new website, reflecting not only the Company’s leadership position in Canada, but its growing international presence and growth ambitions outside of Canada. Organigram Global’s international expansion plans include: Strategic investment in German cannabis leader, Sanity Group, which places the Company in a prime position to grow alongside that market. Sanity holds roughly 7% market share, distributes to over 2,000 pharmacies. Organigram already has two investments in the U.S. creating strategic advantages that expand reach, enhance offerings, and set the Company up for future success. Organigram continues to export premium indoor-grown cannabis to Australia, Germany and the United Kingdom and expects to increase shipments in the coming years. Finally, Organigram continues to identify compelling investment opportunities for Jupiter, the strategic investment pool made possible by BAT’s follow-on investment announced in November 2023. Subject to TSX approval, the Company’s common shares will begin trading on the TSX and NASDAQ under the new name on or about March 31. The trading symbol will remain unchanged as “OGI”.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OGI:
- Organigram Completes Strategic Investment to Boost International Growth
- OrganiGram Holdings Earnings Call Reveals Growth and Challenges
- OrganiGram’s Financial Growth and Strategic Expansion
- Organigram price target lowered to C$3 from C$4.25 at Alliance Global
- Options Volatility and Implied Earnings Moves Today, February 11, 2025